49-20-419. Coverage of exome sequence testing.
(1) As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.
(2) Beginning July 1, 2019, the program shall provide coverage for exome sequence testing: for a covered individual within the state risk pool who: is younger than 21 years of age; and who remains undiagnosed after exhausting all other appropriate diagnostic-related tests; performed by a nationally recognized provider with significant experience in exome sequence testing; that is medically necessary; and at a rate set by the program.